Austin, TX, United States of America

Nianshuang Wang

This inventor holds 6 USPTO granted patents and 10 published patent applications. Top assignees: Dartmouth College, The University of Texas System, Scripps Research Institute. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nianshuang Wang. Retrieved from https://idiyas.com/inventor/nianshuang-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • Hanover, NH (US) (2021)
  • Austin, TX (US) (2024)

Company Filing History:


Years Active: 2021-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Nianshuang Wang: A Pioneer in Protein Engineering

Introduction

Nianshuang Wang is a distinguished inventor based in Austin, TX, recognized for his significant contributions to protein engineering and vaccine development. With a portfolio of three patents, Wang's work primarily focuses on enhancing the safety and efficacy of therapeutic proteins related to coronaviruses and human metapneumovirus (hMPV). His innovative approaches have the potential to impact the fields of diagnostics and immunotherapy significantly.

Latest Patents

Wang's latest patents showcase his expertise in engineering proteins that exhibit crucial stability and antigenicity characteristics. One notable patent titled "Prefusion-stabilized hMPV F proteins" discloses engineered hMPV F proteins that enhance conformational stability and can be utilized as diagnostics, screening platforms, or vaccine components. Another patent, "Prefusion coronavirus spike proteins and their use," involves stabilized coronavirus S ectodomain trimers that can evoke immune responses in subjects, offering a promising direction for treating and preventing coronavirus infections.

Career Highlights

Throughout his career, Nianshuang Wang has worked with prominent institutions including the University of Texas System and the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in these organizations has allowed him to collaborate with leading researchers and contribute to advancing public health through innovative solutions.

Collaborations

Wang has collaborated with esteemed colleagues, including Ching-Lin Hsieh, to push the boundaries of research in protein engineering and infectious disease treatment. These collaborations have fostered a dynamic exchange of ideas, facilitating groundbreaking advancements in vaccine technology and protein design.

Conclusion

Nianshuang Wang represents the forefront of innovation in protein engineering, with his patented work providing valuable insights into potential therapeutic interventions. His contributions not only enhance the understanding of viral proteins but also pave the way for future advancements in vaccine development and public health strategies. Wang's dedication to his field and collaboration with renowned institutions continue to inspire new innovations in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…